Objective: To compare the effectiveness of caudal bupivacaine, bupivacaine plus fentanyl and bupivacaine plus tramadol for post operative analgesia in children. Materials and methods:The study was conducted on 75 children of ASA I and II physical status aged 1 to 12 years undergoing elective infraumbilical surgeries. Patients were divided into 3 groups and the following were given in the caudal epidural space after the induction of anesthesia: a) Group I: 0.125% Inj. Bupivacaine 1ml/kg b) Group II: 0.125 Inj. Bupivacaine 1ml/kg plus Inj. Fentanyl 1mcg/kg c) Group III: 0.125% Inj. Bupivacaine 1ml/kg plus Inj. Tramadol 2mg/kg Results: Group III had a lower pain score, prolonged mean duration of analgesia, less requirement for rescue analgesics compared to the other two groups. Conclusion:Addition of Tramadol to Bupivacaine provides prolonged and good quality post operative analgesia in comparison with Bupivacaine alone or with Fentanyl in Caudal Block in the post operative period.
Background: Cochlear implants are now an acceptable therapeutic option for those patients with irreversible hearing loss and deaf-mutism. The surgery is time consuming and complicated. Hence, the technique of anaesthesia plays a crucial role in success of cochlear implant surgery. Cochlear implant patients have various types of syndromes which are important from anaesthetic as well as surgical point of view. Pre-implant preparation requires objective assessment of hearing, plain X-rays of skull and a CT scan of the temporal bone. Anaesthesia is required for objective assessment of hearing in children under five years of age, to obtain X-rays of skull, Magnetic Resonance Imaging (MRI), CT scan, Brain Evoked Response Audiometry (BERA) testing and finally for cochlear implant surgery. Anaesthetic considerations include preoperative familiarisation with the patient and his family. Syndromal illnesses have specific anaesthetic significance such as presence of difficult airway or prolonged QT interval. Parental presence is highly desirable during induction of anaesthesia. Electro-surgical instruments especially monopolar ones, should not be used once the cochlear implant is in place. Aim: To provide a standard balanced anesthetic management in a patient with Alport Syndrome with sensorineural hearing loss and post renal transplant posted for cochlear implant surgery. Material & Methods: The case includes an eight year old male child with post renal transplant surgery with Alport syndrome where in care has been taken to maintain adequate hemodynamic status & renal function with efficient anesthetic administration. The technique of general anaesthesia was modified to permit use of nerve stimulators during surgery. To minimize the incidence of vertigo particularly after cochleostomy, postoperative nausea and vomiting, the patient received glycopyrrolate and fentanyl citrate intravenously prior to induction. Other agents used were, thiopentone, suxamethoniumand end-tidal 1 MAC sevofluranein 1:2 mixture of oxygen and nitrous oxide (O2 and N2 O). Electro diathermy was switched off, before the cochlear device was implanted on the patient. Patient was allowed to breathe spontaneously whenever nerve stimulator was used to locate the facial nerve. Inj Ondansetron 0.1 mg/kg was used as anti-emetic agent. Postoperative pain relief was initially provided with fentanyl 1 µg/kg IV and later with syrup ibuprofen. Conclusion: The study throws light upon the precautions & preliminary methods followed in providing balanced anesthesia to the patient of Alport syndrome with renal transplant undergoing the cochlear implant surgery. Complicated patients with syndromic features have to be managed carefully in order to avoid various anesthetic complications. There was no remarkable anaesthetic or surgical complication
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.